TS Financial Group (TSFG)’s Passage Bio PASG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$0 Hold
5
﹤0.01% 903
2026
Q1
$0 Hold
5
﹤0.01% 867
2025
Q4
$0 Hold
5
﹤0.01% 868
2025
Q3
$0 Hold
5
﹤0.01% 883
2025
Q2
$0 Hold
5
﹤0.01% 857
2025
Q1
$0 Hold
5
﹤0.01% 847
2024
Q4
$0 Hold
5
﹤0.01% 798
2024
Q3
$0 Hold
5
﹤0.01% 830
2024
Q2
$0 Hold
5
﹤0.01% 794
2024
Q1
$0 Hold
5
﹤0.01% 872
2023
Q4
$0 Hold
5
﹤0.01% 997
2023
Q3
$1K Hold
5
﹤0.01% 983
2023
Q2
$0 Hold
5
﹤0.01% 1040
2023
Q1
$0 Hold
5
﹤0.01% 994
2022
Q4
$0 Hold
5
﹤0.01% 1009
2022
Q3
$0 Hold
5
﹤0.01% 1014
2022
Q2
$0 Hold
5
﹤0.01% 1044
2022
Q1
$0 Hold
5
﹤0.01% 988
2021
Q4
$1K Hold
5
﹤0.01% 843
2021
Q3
$1K Buy
+5
New +$1.19K ﹤0.01% 824

Other funds holding PASG

TS Financial Group (TSFG)'s PASG Position: Q2 2026 in Review

TS Financial Group (TSFG) held its Passage Bio (PASG) position steady in Q2 2026 at 5 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #903.

TS Financial Group (TSFG) first reported a position in PASG in Q3 2021 and has held it in 20 quarters since. The position peaked at $1K in Q3 2023. 5 funds tracked by Wall St. Rank hold PASG as of Q2 2026.

  • TS Financial Group (TSFG) held 5 shares of Passage Bio worth $0 as of Q2 2026.
  • TS Financial Group (TSFG) left its Passage Bio share count unchanged in Q2 2026.
  • Passage Bio made up ﹤0.01% of TS Financial Group (TSFG)'s portfolio in Q2 2026, its #903 holding.
  • TS Financial Group (TSFG) first reported a position in Passage Bio in Q3 2021 and has held it in 20 quarters since.
  • TS Financial Group (TSFG)'s Passage Bio position peaked at $1K in Q3 2023.
  • 5 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.

Based on TS Financial Group (TSFG)'s 13F filing for Q2 2026, filed 23 Jul 2026.